Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis image

Another approval for Novartis’ everolimus

February 18, 2013
Sales and Marketing Certican, Novartis, Zortress, everolimus

Novartis has gained US approval for its drug Zortress (everolimus) to prevent liver transplant rejection.Zotress is already used to prevent …

News
Lantus image

Insulin blockbusters targeted by biosimilar blitz

February 15, 2013
Research and Development, Sales and Marketing Biocon, Humalog, Mylan, insulin

Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …

News
janssen image

Janssen launches dementia prize

February 15, 2013
Sales and Marketing Hunt, Janssen, NHS, dementia

Janssen has joined forces with the NHS to launch a scheme to financially reward solutions which can help the lives …

News
cameron image

Fundraising to fuel e-Therapeutics’ ‘network pharmacology’

February 15, 2013
Research and Development e-Therapeutics

Drug discovery and development firm e-Therapeutics hopes to raise £40 million via a new share offer to fund its research …

News

Lancet sparks agency row

February 15, 2013
Medical Communications, Sales and Marketing ABPI, Lancet, Luther Pendragon, Marlboro, Phillip Morris

Communications agency Luther Pendragon has parted company with cigarette firm Philip Morris after attention was drawn to the agency’s other …

News
screen_shot_2013-02-15_at_14

Nanobiotix appoints ex-Sanofi head Alain Herrera

February 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix

Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …

Appointment

BMS hires Ann Powell Judge from Shire

February 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Powell Judge, BMS, Shire

BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …

Appointment
Shire image

Shire ADHD drug for UK

February 14, 2013
Sales and Marketing ADHD, Shire, Vyvanse, elvanse

Shire’s attention-deficit hyperactivity disorder (ADHD) drug Elvanse has been given the go-ahead for use in the UK. Elvanse (lisdexamfetamine dimesylate), …

News
cost value image

Delivering value in cost-constrained healthcare environments

February 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, MSI, NHS, VBP, austerity, value

As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …

Feature
BMS image

BMS in $438m OTC deal

February 14, 2013
Sales and Marketing BMS, Reckitt Benckiser

Bristol-Myers Squibb has signed over the rights to sell, distribute and market half a dozen of its medicines, mainly sold …

News

Universal WorldEvents creates dedicated training role

February 14, 2013
Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents

Event management firm Universal WorldEvents has announced the promotion of Sarah Longland to the new role of senior account manager …

Appointment
NICE image

NICE rejects Jakavi

February 13, 2013
Sales and Marketing Jakavi, NICE

NICE has today issued draft guidance saying it does not recommend Novartis’ Jakavi for patients with myelofibrosis, a rare blood …

News
currie_mark_ironwood

Ironwood announces new president of R&D

February 13, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Ironwood

Ironwood Pharmaceuticals has announced the promotion of Mark Currie, to senior vice president, chief scientific officer, and president of research …

Appointment
regeneron image

Sanofi ups stake in Regeneron

February 13, 2013
Sales and Marketing AMD, Regeneron, Sanofi, Zaltrap

Sanofi is increasing its stake in Regeneron Pharmaceuticals by buying shares on the open market and from existing shareholders. The …

News
Shire image

Shire pays Impax $48 million

February 12, 2013
Sales and Marketing ADHD, Adderall, Impax, Shire

Shire has paid $48 million to settle a long-running legal spat with Impax Laboratories over Shire’s supply of an authorised …

News
Perrigo image

Perrigo buys Rosemont for £180 million

February 12, 2013
Manufacturing and Production Perrigo, Rosemont

UK-based Rosemont Pharmaceuticals has been sold by its private equity owner to Perrigo of the US in a £180 million …

News
rajiv_malik

Mylan appoints two heads to Board of directors

February 12, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Mylan

Mylan has announced the appointment of Melina Higgins, a former partner at Goldman Sachs, and Rajiv Malik, currently Mylan’s president, …

Appointment
Novo Nordisk image

FDA rejects Novo diabetes drugs

February 12, 2013
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba

The FDA has knocked back two of Novo Nordisk’s diabetes drugs – just weeks after they were approved for use …

News
Merck image

Merck planning more manufacturing cutbacks?

February 11, 2013
Manufacturing and Production Merck, restructuring

Merck & Co has said it intends to make additional reductions to its manufacturing network, although the pace of restructuring …

News
FDA image

FDA offers Alzheimer’s guidance

February 11, 2013
Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026